What is the current Price Target for the Astria Therapeutics stock?

The average Astria Therapeutics target price is $22.95. This is 84.49% higher than the current stock price. The highest price target is 313.59%, the lowest is 5.55%. 8 Analysts have issued a price target Astria Therapeutics 2026 .

How high will the Astria Therapeutics stock rise?

No reliable answer can be given as to how high the Astria Therapeutics stock will rise. The performance of stocks, including the Astria Therapeutics stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Astria Therapeutics stock today?

The performance of Astria Therapeutics stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Astria Therapeutics stock fall?

The decline in Astria Therapeutics stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Astria Therapeutics Forecast, price target & analysts

$12.44

0.40% yesterday

NYSE, Nov 19, 10:00 pm CET

ISIN

US04635X1028

Symbol

ATXS

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Astria Therapeutics Target price 2025 - Analyst rating & recommendation

Astria Therapeutics Classifications & Recommendation:

Buy

57%

Hold

43%

Astria Therapeutics Price Target

Target Price	$22.95
Price	$12.44
Potential	84.49% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Astria Therapeutics 2026 . The average Astria Therapeutics target price is $22.95. This is 84.49% register free of charge higher than the current stock price. The highest price target is $51.45 313.59% register free of charge , the lowest is $13.13 5.55% register free of charge .
	A rating was issued by 14 analysts: 8 Analysts recommend Astria Therapeutics to buy, 6 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Astria Therapeutics stock has an average upside potential 2026 of 84.49% register free of charge . Most analysts recommend the Astria Therapeutics stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.68	-2.12
	30.58%	26.19%
P/E		negative
EV/Sales		32.55

10 Analysts have issued a Astria Therapeutics forecast for earnings per share. The average Astria Therapeutics EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.68	30.58%
2025	$-2.12 26.19% Unlock
2026	$-2.28 7.55% Unlock
2027	$-2.02 11.40% Unlock
2028	$-1.97 2.48% Unlock
2029	$-0.82 58.38% Unlock
2030	$-0.12 85.37% Unlock
2031	$1.44 1,300.00% Unlock
2032	$2.19 52.08% Unlock

Current	-6.18	14.16%
2025	-5.89 4.74% Unlock
2026	-5.48 6.96% Unlock
2027	-6.19 12.96% Unlock
2028	-6.34 2.42% Unlock
2029	-15.21 139.91% Unlock
2030	-106.48 600.07% Unlock
2031	8.68 108.15% Unlock
2032	5.70 34.33% Unlock

Astria Therapeutics...

Current Astria Therapeutics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Cantor Fitzgerald	Locked ➜ Locked	Locked	Nov 12 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 16 2025
Wedbush	Locked ➜ Locked	Locked	Oct 15 2025
JMP Securities	Locked ➜ Locked	Locked	Oct 15 2025
Jefferies	Locked ➜ Locked	Locked	Oct 14 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Sep 17 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 17 2025

Analyst Rating	Date
Locked Cantor Fitzgerald: Locked ➜ Locked	Nov 12 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 16 2025
Locked Wedbush: Locked ➜ Locked	Oct 15 2025
Locked JMP Securities: Locked ➜ Locked	Oct 15 2025
Locked Jefferies: Locked ➜ Locked	Oct 14 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Sep 17 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 17 2025

Discover more stocks with a high price target

Netflix 1,188.91%

Coinbase Global, Inc. 60.16%

Adidas 56.77%

Meta Platforms (Facebook) 51.19%

Novo Nordisk 50.22%

TUI 48.57%

Deutsche Telekom 42.71%

BYD 42.26%

Adyen 41.37%

Rheinmetall 40.60%

BioNTech SE - ADR 37.27%

Walt Disney 34.48%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now